Naiba Nabieva

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Total lipid, phospholipid and cholesterol content in the tissues of the liver, myocardium, skeletal muscle, intestine and the blood plasma was studied on three groups of rats (control, thyroidectomized, and thyroidectomized to which l-thyroxin was administered); the animals were aged 2, 6 months and 2 years. All the indices studied increased in the tissues(More)
PURPOSE This study describes comprehensive data from a breast cancer registry concerning the use of endocrine treatment (ET) and chemotherapy in the first, second and higher therapy lines in hormone receptor (HR) positive, HER2 negative metastatic breast cancer (MBC). METHODS The PRAEGNANT study is a real-time registry for patients with MBC. Therapies(More)
Purpose Patient-reported outcomes (PROs) have been incorporated into clinical trials for many symptoms and medical conditions. A transition from paper-based capture of PROs to electronic PROs (ePROs) has recently started. This study reports on the feasibility of ePRO assessment in a prospective registry including molecular data for patients with advanced(More)
PURPOSE Patient-reported outcomes (PROs) have been incorporated into clinical trials for many symptoms and medical conditions. A transition from paper-based capture of PROs to electronic PROs (ePROs) has recently started. This study reports on the feasibility of ePRO assessment in a prospective registry including molecular data for patients with advanced(More)
Background Patients' compliance and persistence with endocrine treatment has a significant effect on the prognosis in early breast cancer (EBC). The purpose of this analysis was to identify possible reasons for non-persistence, defined as premature cessation of therapy, on the basis of patient and tumor characteristics in individuals receiving adjuvant(More)
  • 1